生物可降解与耐久聚合物依维莫司洗脱支架对STEMI患者新生动脉粥样硬化的长期影响:CONNECT试验
CONNECT试验随机将239例STEMI患者分配至BP-EES或DP-EES行直接PCI,3年OCT评估新生动脉粥样硬化频率。
要点
- STEMI直接PCI后3年,BP-EES与DP-EES新生动脉粥样硬化频率无显著差异。
- 纤维粥样斑块和巨噬细胞聚集频率两组相似,未观察到纤维钙化性新生动脉粥样硬化。
核心结论
- STEMI患者直接PCI使用BP-EES在3年新生动脉粥样硬化频率上不优于DP-EES。
研究设计与样本
- 随机对照、多中心(日本和瑞士)CONNECT试验(NCT03440801),1:1随机分配239例STEMI患者至BP-EES或DP-EES行直接PCI。
- 主要终点为3年时OCT评估的新生动脉粥样硬化频率。
主要发现
- 236例接受支架植入(BP-EES 119例;DP-EES 117例),178例(75%)完成3年OCT评估。
关键数值与推荐
- 新生动脉粥样硬化定义为新内膜内出现纤维粥样斑块、纤维钙化斑块或巨噬细胞聚集。
临床怎么用
- 对于STEMI行直接PCI的患者,选择BP-EES或DP-EES在3年新生动脉粥样硬化及靶病变失败方面未见显著差异。
局限性
- 3年OCT评估完成率为75%(178/236),部分患者未纳入主要终点分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Neoatherosclerosis is a leading cause of late (>1 year) stent failure following drug-eluting stent implantation. The role of biodegradable (BP) vs. durable polymer (DP) drug-eluting stents on long-term occurrence of neoatherosclerosis remains unclear. Superiority of biodegradable against durable polymer current generation thin-strut everolimus-eluting stent (EES) was tested by assessing the frequency of neoatherosclerosis 3 years after primary percutaneous coronary intervention (pPCI) among patients with ST-segment elevation myocardial infarction (STEMI). METHODS: The randomized controlled, multicentre (Japan and Switzerland) CONNECT trial (NCT03440801) randomly (1:1) assigned 239 STEMI patients to pPCI with BP-EES or DP-EES. The primary endpoint was the frequency of neoatherosclerosis assessed by optical coherence tomography (OCT) at 3 years. Neoatherosclerosis was defined as fibroatheroma or fibrocalcific plaque or macrophage accumulation within the neointima. RESULTS: Among 239 STEMI patients randomized, 236 received pPCI with stent implantation (119 BP-EES; 117 DP-EES). A total of 178 patients (75%; 88 in the BP-EES group and 90 in the DP-EES group) underwent OCT assessment at 3 years. Neoatherosclerosis did not differ between the BP-EES (11.4%) and DP-EES (13.3%; odds ratio 0.83, 95% confidence interval 0.33-2.04, P = .69). There were no differences in the frequency of fibroatheroma (BP-EES 9.1% vs. DP-EES 11.1%, P = .66) or macrophage accumulation (BP-EES 4.5% vs. DP-EES 3.3%, P = .68), and no fibrocalcific neoatherosclerosis was observed. Rates of target lesion failure did not differ between groups (BP-EES 5.9% vs. DP-EES 6.0%, P = .97). CONCLUSIONS: The use of BP-EES for primary PCI in patients presenting with STEMI was not superior to DP-EES regarding frequency of neoatherosclerosis at 3 years.
引用
- Taniwaki M, Häner JD, Kakizaki R, et al. Long-term effect of biodegradable vs. durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial. Eur Heart J. 2025. PMID: 39217617. doi:10.1093/eurheartj/ehae589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。